Happy Tuesday! I wanted to share our latest ATD blog post, which explains that the biggest obstacle to widespread virtual reality (VR) learning adoption is dabbling – a lot of learning organizations are (for a variety of reasons, some out of their control) dabbling (puttering, fiddling, etc.) with pilots and proofs of concept that are too small and unimaginative to be transformative. The intent is to make sure the VR approach makes sense, which is understandable, but the effort is often counterproductive because half-measures rarely show the sort of wow! results that full adoption yield.
Meanwhile, companies like Takeda, Novartis, and Bristol Myers Squibb are realizing the wow! by starting with a strategic plan and serious budget commitment that energizes the entire enterprise from the outset.
We have just the events for you if you’re ready to deploy VR learning systematically. I'm beyond excited about the opportunity to host the Training Magazine Network's "Learning From the Leading Edge" quarterly panel discussion series. We're starting with a bang on March 2nd, featuring the greatest minds in the industry: Professors Karl Kapp, Tony O'Driscoll, and David Metcalf. They'll share their insights on how the metaverse will transform enterprise learning.
We’re also presenting a demo-packed webinar for the Life Sciences Trainers & Educators Network (LTEN) looking at our recent cell and gene therapy VR cleanroom training for Pfizer, Takeda, Novartis and Bristol Myers Squibb.
Finally, the ATD 2023 International Conference & Exposition in San Diego is coming up. We’ll be presenting success stories from the frontlines of the learning metaverse. Let's meet and catch up.